Literature DB >> 16411892

RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.

Liming Jin1, Arthur L Burnett.   

Abstract

Penile erection is a complicated event involving the regulation of corpus cavernosal smooth muscle tone. Recently, the small monomeric G-protein RhoA and its downstream effector Rho-kinase have been proposed to be important players for mediating vasoconstriction in the penis. RhoA/Rho-kinase increases MLC (myosin light chain) phosphorylation through inhibition of MLCP (MLC phosphatase) thereby increasing Ca2+ sensitivity. This review will outline the RhoA/Rho-kinase signalling pathway, including the upstream regulators, guanine nucleotide exchange factors, GDP dissociation inhibitors and GTPase-activating proteins. We also summarize the current knowledge about the physiological roles of RhoA/Rho-kinase in both male and female erectile tissues and its aberrations contributing to erectile dysfunction in several disease states. Understanding the RhoA/Rho-kinase signalling pathway in the regulation of erection is important for the development of therapeutic interventions for erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16411892     DOI: 10.1042/CS20050255

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  22 in total

1.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

2.  Erectile function is improved in aged rats by PnTx2-6, a toxin from Phoneutria nigriventer spider venom.

Authors:  Kenia P Nunes; Haroldo A Toque; Marcia H Borges; Michael Richardson; R Clinton Webb; Maria Elena de Lima
Journal:  J Sex Med       Date:  2012-08-23       Impact factor: 3.802

Review 3.  Understanding and targeting the Rho kinase pathway in erectile dysfunction.

Authors:  Nikolai A Sopko; Johanna L Hannan; Trinity J Bivalacqua
Journal:  Nat Rev Urol       Date:  2014-10-14       Impact factor: 14.432

Review 4.  Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction.

Authors:  Eric Chung; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

5.  The effect of sub-chronic systemic ethanol treatment on corpus cavernosal smooth muscle contraction: the contribution of RhoA/Rho-kinase.

Authors:  Eda Karabal Kumcu; Fatma Aydinoglu; Erhan Astarci; Nuran Ogulener
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-04       Impact factor: 3.000

Review 6.  Molecular Yin and Yang of erectile function and dysfunction.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Zhong Wang; Guiting Lin; Tom F Lue
Journal:  Asian J Androl       Date:  2008-05       Impact factor: 3.285

7.  Erectile dysfunction and its management in patients with diabetes mellitus.

Authors:  Giuseppe Defeudis; Daniele Gianfrilli; Chiara Di Emidio; Riccardo Pofi; Dario Tuccinardi; Andrea Palermo; Andrea Lenzi; Paolo Pozzilli
Journal:  Rev Endocr Metab Disord       Date:  2015-10-26       Impact factor: 6.514

Review 8.  RhoA/Rho-kinase: pathophysiologic and therapeutic implications in gastrointestinal smooth muscle tone and relaxation.

Authors:  Satish Rattan; Benjamin R Phillips; Pinckney J Maxwell
Journal:  Gastroenterology       Date:  2009-11-23       Impact factor: 22.682

9.  Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice.

Authors:  Fernanda B M Priviero; Li-Ming Jin; Zhekang Ying; Cleber E Teixeira; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2010-01-21       Impact factor: 4.030

10.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.